Back

Non-invasive risk prediction based on right ventricular function in patients with pulmonary arterial hypertension

30 August 2021 (07:15 - 07:24)
Organised by:
Congress Presentation Part of: Pulmonary arterial hypertension: risk stratification guides for new treatments and informed outcomes Pulmonary Hypertension ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Mrs Vazhma Qaderi

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

4 More presentations in this session

Presentation thumbnail
Inclusion of echocardiographic measure of right ventricular function in the non-invasive French pulmonary arterial hypertension risk stratification method
Doctor C. Fauvel (Rouen, FR)
Abstract Slides Video
Presentation thumbnail
Twenty-year experience and outcomes in a national paediatric pulmonary hypertension service
Doctor A. Constantine (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
Safety, tolerability, and pharmacokinetics (PK) of treprostinil palmitil inhalation powder (TPIP): a phase 1, randomised, double-blind, single- and multiple-dose study
Doctor F. Ismat (Bridgewater, US)
Abstract Slides Video
Presentation thumbnail
Treatment effect of selexipag on time to disease progression when initiated early in pulmonary arterial hypertension (PAH) patients: GRIPHON and TRITON pooled analysis
Doctor J. Coghlan (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Pulmonary arterial hypertension: risk stratification guides for new treatments and informed outcomes

The Event

Event poster

ESC Congress 2021 - The Digital Experience

30 August 2021 07:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources